All Stories
Follow
Subscribe to Mologen AG

Mologen AG

ots Ad hoc-Service: Mologen Holding AG <DE0006637200> Mologen: New acquisition and new co-operation

Berlin (ots Ad hoc-Service) -

Ad hoc-announcement. The sender is solely
responsible for the contents of this announcement.
Mologen Holding AG has acquired 51%
of bcd biomedical consulting + development GmbH in Berlin. bcd is
specialised in providing services and R&D-capacity for genetic
vaccination and somatic gene therapy in animals. bcd and Mologen
expect from this deal a powerful combination
of the specific know how of both companies.
Mologen regard this investment as another important strategic
element for strengthening their application-oriented R&D. The
establishment of the wholly owned Mologen Molecular Medicine S.L. in
Spain in 2000 has been the first step in realising this strategy.
A further element is a co-operation with Weston Medical Group plc.
Both companies have started to develop new application methods for
genetic vaccination of humans by combining the core technologies of
both companies. Mologen contributes the MIDGE technology, Weston
Medical provides with Intraject one of the leading technologies in
needlefree injection.
For further information please go to www.mologen.com.
WKN: 663720; Index: Listed: Freiverkehr in Berlin, Frankfurt,
Hamburg, München und Stuttgart
End
Internet: http://recherche.newsaktuell.de

Original content of: Mologen AG, transmitted by news aktuell